TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2015

Randomized phase III trial of gemcitabine plus docetaxel plus bevacizumab or placebo as first-line treatment for metastatic uterine leiomyosarcoma: an NRG Oncology/Gynecologic Oncology Group study.

Martee L Hensley et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.